Vilius Skipskis

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction

Tajinder Kumar Parpugga, Vacis Tatarūnas, Vilius Skipskis et al. · Disease Markers · 2015 · 20 citations · Full text

Genetic Epidemiology, Human Polymorphism, Coronary Artery Disease +20

Effect of Clinical Factors and Gene Polymorphism of <i>CYP2C19*2</i> , <i>*17</i> and <i>CYP4F2*3</i> on Early Stent Thrombosis

Nora Kupstytė, Remigijus Žaliūnas, Vacis Tatarūnas et al. · Pharmacogenomics · 2015 · 18 citations

The role of clinical parameters and of CYP2C19 G681 and CYP4F2 G1347A polymorphisms on platelet reactivity during dual antiplatelet therapy

Vacis Tatarūnas, Laima Jankauskienė, Nora Kupstytė et al. · Blood Coagulation & Fibrinolysis · 2014 · 17 citations

Immunology, Platelet Reactivity, Pharmacotherapy +20

The Impact of <i>CYP2C19</i> and <i>CYP4F2</i> Variants and Clinical Factors on Treatment Outcomes During Antiplatelet Therapy

Vacis Tatarūnas, Nora Kupstytė-Krištaponė, Rita Norvilaitė et al. · Pharmacogenomics · 2019 · 15 citations

The Impact of Trimethylamine N-Oxide and Coronary Microcirculatory Dysfunction on Outcomes following ST-Elevation Myocardial Infarction

Ali Aldujeli, Riddhi Patel, Ingrida Grabauskytė et al. · Journal of Cardiovascular Development and Disease · 2023 · 14 citations · Full text